Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Diehm

Showing results (141-150 of 165) with videos related to

Pageof 17
Sort By:
Der Internist|August 31, 2010
[Anticoagulation in the elderly]J Harenberg, R Bauersachs, C Diehm, et al.
European Journal of Clinical Investigation|August 20, 2003
Are elevated homocysteine plasma levels related to peripheral arterial disease? Results from a cross-sectional study of 6880 primary care patientsH Darius, D Pittrow, R Haberl, et al.
International Angiology : a Journal of the International Union of Angiology|October 1, 1991
Reduction of ischaemic rest pain in advanced peripheral arterial occlusive disease. A double blind placebo controlled trial with iloprostK Balzer, G Bechara, H Bisler, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1992
Guidelines for therapeutic studies on peripheral arterial occlusive disease in Fontaine stages II-IV. German society of AngiologyH Heidrich, J Allenberg, M Cachovan, et al.
Schweizerische Medizinische Wochenschrift|October 6, 1990
[Iloprost in the treatment of ischemic tissue lesions in diabetics. Results of a placebo-controlled multicenter study with a stable prostacyclin derivative]F E Brock, O Abri, G Baitsch, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|June 18, 2010
The next 10 years in the management of peripheral artery disease: perspectives from the 'PAD 2009' ConferenceL Norgren, W R Hiatt, J A Dormandy, et al.
Deutsche Medizinische Wochenschrift (1946)|December 26, 2006
[Metabolic syndrome and peripheral arterial occlusive disease as indicators for increased cardiovascular risk]C Diehm, H Darius, D Pittrow, et al.
VASA. Supplementum|January 1, 1989
Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease--a controlled randomised multicenter studyG Trübestein, S von Bary, K Breddin, et al.
Deutsche Medizinische Wochenschrift (1946)|May 11, 1984
[Naftidrofuryl in arterial occlusive disease. Controlled multicenter double-blind study with oral administration]U Maass, H G Amberger, H Böhme, et al.
VASA. Supplementum|January 1, 1987
[Prevalence and risk factors of peripheral arterial occlusive diseases and coronary heart disease]U Müller-Bühl, C Diehm, U Sieben, et al.
Pageof 17

Showing results (141-150 of 165) with videos related to

Sort By:
Pageof 17
Der Internist|August 31, 2010
[Anticoagulation in the elderly]J Harenberg, R Bauersachs, C Diehm, et al.
European Journal of Clinical Investigation|August 20, 2003
Are elevated homocysteine plasma levels related to peripheral arterial disease? Results from a cross-sectional study of 6880 primary care patientsH Darius, D Pittrow, R Haberl, et al.
International Angiology : a Journal of the International Union of Angiology|October 1, 1991
Reduction of ischaemic rest pain in advanced peripheral arterial occlusive disease. A double blind placebo controlled trial with iloprostK Balzer, G Bechara, H Bisler, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1992
Guidelines for therapeutic studies on peripheral arterial occlusive disease in Fontaine stages II-IV. German society of AngiologyH Heidrich, J Allenberg, M Cachovan, et al.
Schweizerische Medizinische Wochenschrift|October 6, 1990
[Iloprost in the treatment of ischemic tissue lesions in diabetics. Results of a placebo-controlled multicenter study with a stable prostacyclin derivative]F E Brock, O Abri, G Baitsch, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|June 18, 2010
The next 10 years in the management of peripheral artery disease: perspectives from the 'PAD 2009' ConferenceL Norgren, W R Hiatt, J A Dormandy, et al.
Deutsche Medizinische Wochenschrift (1946)|December 26, 2006
[Metabolic syndrome and peripheral arterial occlusive disease as indicators for increased cardiovascular risk]C Diehm, H Darius, D Pittrow, et al.
VASA. Supplementum|January 1, 1989
Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease--a controlled randomised multicenter studyG Trübestein, S von Bary, K Breddin, et al.
Deutsche Medizinische Wochenschrift (1946)|May 11, 1984
[Naftidrofuryl in arterial occlusive disease. Controlled multicenter double-blind study with oral administration]U Maass, H G Amberger, H Böhme, et al.
VASA. Supplementum|January 1, 1987
[Prevalence and risk factors of peripheral arterial occlusive diseases and coronary heart disease]U Müller-Bühl, C Diehm, U Sieben, et al.
Pageof 17